Readout newsletter: Bristol Myers, Bernie Sanders, Ozempic
27 Apr 2024
STAT

Senate health committee chair Bernie Sanders has launched an investigation into the "outrageously high price" of Novo Nordisk's blockbuster drugs Ozempic and Wegovy.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. Here in Chicago, residents are reeling over the removal of the famed rat hole, a rat-shaped indentation on a piece of sidewalk that drew crowds, fans, and even a proposal and a marriage.
The need-to-know this morning
A hospital takes a gene therapy’s approval into its own hands
What happens if, as an academic, you develop a promising gene therapy, but no company is willing to take it to market? Well, one option is — you do it yourself.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
Individual plans
Group plans
Get unlimited access to award-winning journalism and exclusive events.
Subscribe